1. Home
  2. PCVX vs CCK Comparison

PCVX vs CCK Comparison

Compare PCVX & CCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • CCK
  • Stock Information
  • Founded
  • PCVX 2013
  • CCK 1906
  • Country
  • PCVX United States
  • CCK United States
  • Employees
  • PCVX N/A
  • CCK N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • CCK Containers/Packaging
  • Sector
  • PCVX Health Care
  • CCK Industrials
  • Exchange
  • PCVX Nasdaq
  • CCK Nasdaq
  • Market Cap
  • PCVX 4.0B
  • CCK 11.2B
  • IPO Year
  • PCVX 2020
  • CCK N/A
  • Fundamental
  • Price
  • PCVX $32.59
  • CCK $95.32
  • Analyst Decision
  • PCVX Strong Buy
  • CCK Strong Buy
  • Analyst Count
  • PCVX 8
  • CCK 13
  • Target Price
  • PCVX $114.17
  • CCK $121.23
  • AVG Volume (30 Days)
  • PCVX 1.6M
  • CCK 1.3M
  • Earning Date
  • PCVX 11-04-2025
  • CCK 10-16-2025
  • Dividend Yield
  • PCVX N/A
  • CCK 1.09%
  • EPS Growth
  • PCVX N/A
  • CCK 31.02
  • EPS
  • PCVX N/A
  • CCK 4.73
  • Revenue
  • PCVX N/A
  • CCK $12,013,000,000.00
  • Revenue This Year
  • PCVX N/A
  • CCK $4.13
  • Revenue Next Year
  • PCVX N/A
  • CCK $2.73
  • P/E Ratio
  • PCVX N/A
  • CCK $20.13
  • Revenue Growth
  • PCVX N/A
  • CCK 2.23
  • 52 Week Low
  • PCVX $27.66
  • CCK $75.98
  • 52 Week High
  • PCVX $121.06
  • CCK $109.48
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 53.03
  • CCK 41.62
  • Support Level
  • PCVX $31.47
  • CCK $93.51
  • Resistance Level
  • PCVX $33.16
  • CCK $96.76
  • Average True Range (ATR)
  • PCVX 1.37
  • CCK 1.94
  • MACD
  • PCVX 0.07
  • CCK 0.10
  • Stochastic Oscillator
  • PCVX 67.76
  • CCK 40.81

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About CCK Crown Holdings Inc.

Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

Share on Social Networks: